Business

Albert Invent Partners with Kenvue to Build the Future of Consumer Health Products With the Help of AI

SUMMIT, N.J. & OAKLAND, Calif., October 14, 2025--Frontier AI company Albert Invent today announced a strategic partnership with Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Zyrtec®, Neutrogena®, and Listerine®, to accelerate end-to-end R&D efforts across the company’s global portfolio of brands. The partnership enables Kenvue to streamline, digitalize, and accelerate the end-to-end product lifecycle by leveraging Albert Invent's foundational AI models.

articleKenvue Inc.October 14, 20254/company/kenvue-inc/news/albert-invent-partners-with-kenvue-to-build-the-future-of-consumer-health-products-with-the-help-of-ai
Albert Invent Partners with Kenvue to Build the Future of Consumer Health Products With the Help of AI

About this update from Kenvue Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2000,"height":540,"url":"https://media.zenfs.com/en/business-wire.com/a61c3b4ba3b554edd99591def15564c6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/j2kAL7zQrSyAB6tVYi1hjQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI1OTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/a61c3b4ba3b554edd99591def15564c6","width":960,"height":259},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/gdWDaMGlCQzV4lzJcoB4tg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD02NDg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/a61c3b4ba3b554edd99591def15564c6","width":1200,"height":324}},"lazy":false},{"type":"text","content":"SUMMIT, N.J. & OAKLAND, Calif., October 14, 2025--(BUSINESS WIRE)--Frontier AI company Albert Invent today announced a strategic partnership with Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Zyrtec®, Neutrogena®, and Listerine®, to accelerate end-to-end R&D efforts across the company’s global portfolio of brands. The partnership enables Kenvue to streamline, digitalize, and accelerate the end-to-end product lifecycle by leveraging Albert Invent's foundational AI models.","length":506,"tagName":"p"},{"type":"text","content":"The companies began working together starting in Q1 2025 as part of a multi-year partnership set to drive value for scientists by streamlining hundreds of R&D processes and methodologies across the globe. The focus of the partnership is to augment and accelerate the work of Kenvue's global workforce of scientists with Albert Invent's end-to-end AI platform, with the goal of simplifying processes to gain efficiencies both inside and outside of the lab and allowing these incredible scientists to meet evolving consumer needs with even greater impact.","length":565,"tagName":"p"},{"type":"text","content":""While we have many digitally-led initiatives, our collaboration with Albert Invent is 100% focused on enhancing how our scientists create products for our consumers," said Dave Lutness, Head of R&D Digital Capabilities and Platforms at Kenvue. "With the expertise both at Kenvue and with Albert Invent, we are integrating AI into the work we do every day, in service of our brands that billions of people have come to find ...

More updates from Kenvue Inc.

Albert InventAI companyconsumer health productsKenvueconsumer health